NCT01574820View on ClinicalTrials.gov

Role of Rosiglitazone on Pre-Diabetes Mellitus and Coronary Artery Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

August 31, 2010

Study Completion Date

July 31, 2011

Conditions
PrediabetesCoronary Artery DiseaseInsulin ResistanceGlucose Intolerance
Interventions
DRUG

placebo tablet

placebo tablet for 6 months

DRUG

rosiglitazone (4 mg)/day

rosiglitazone (4 mg)/day for 6 months

All Listed Sponsors
lead

National Cheng-Kung University Hospital

OTHER

NCT01574820 - Role of Rosiglitazone on Pre-Diabetes Mellitus and Coronary Artery Disease | Biotech Hunter | Biotech Hunter